Skip to content

Clinical trials

Observational Overweight trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Phase: Observational Country / region: United States Clear all

112 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20052
20063
20075
20085
20093
20101
20111
20123
20131
20145
20154
20166
20175
20187
20196
20207
20214
20225
202310
20244
202512
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed72
Recruiting19
Active, not recruiting6
Enrolling by invitation5
Unknown status3
Withdrawn3
Not yet recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S7
Brigham and Women's Hospital5
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5
Duke University4
Massachusetts General Hospital4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3
Johns Hopkins University3
Pennington Biomedical Research Center3
USDA Grand Forks Human Nutrition Research Center3
University of California, San Diego3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight112
Obesity101
Diabetes Mellitus, Type 211
Weight Loss11
Hypertension10
Insulin Resistance6
Body Weight5
Diabetes Mellitus5
Cardiovascular Diseases4
Neoplasms4

Trials

Showing 1 to 25 of 112. Each trial links to its page on Pharma Observatory.

12 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.